Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
MYO vs CDRE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
CDRE Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)
CDRE Overall Winner
6-Pillar Tally: MYO 1 – 5 CDRE
Matrix Metrics: MYO 1 – 9 CDRE
As of Nov 20, 2026, Cadre Holdings, Inc. (CDRE) is the stronger overall head-to-head candidate over Myomo Inc. (MYO) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MYO carries a Unified Composite Score of 40.1/100 (SELL) at $0.81 (N/M Forward P/E, -21.8% operating margin), whereas CDRE carries 39.6/100 (SELL) at $29.45 (18.5x Forward P/E, 12.5% operating margin).
- Defensive Composite Rating Caution: Although CDRE compares more favorably head-to-head, both MYO (40.1/100 SELL) and CDRE (39.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
- Technical & Structure Timing Caution: MYO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.7); meanwhile CDRE trades in a Neutral technical trend (SURGE options phase, RSI 42.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About MYO vs CDRE
MYO
Myomo Inc.
$0.81
-3.45% 1D
Market Cap
$33.7M
TTM Revenue
$46M
Forward P/E
N/M
Beta / 30D Vol
2.22β · 107% Vol
Unified Composite Score
40.1
SELL
Tech 25.0
Fund 43.0
Flow 58.0
Mom 59.0
Weinstein Technical Phase
Markdown · Sell / avoid
CDRE
Head-to-Head Winner
Cadre Holdings, Inc.
$29.45
-3.63% 1D
Market Cap
$1.3B
TTM Revenue
$733M
Forward P/E
18.5x
Beta / 30D Vol
0.87β · 42% Vol
Unified Composite Score
39.6
SELL
Tech 15.0
Fund 40.0
Flow 55.0
Mom 60.0
Weinstein Technical Phase
Neutral · Hold
6-Pillar Scorecard Institutional Category Breakdown (MYO 1 – 5 CDRE)
1. Valuation Multiples
CDRE
Forward P/E
N/M
18.5x
Trailing P/E
N/M
33.6x
PEG Ratio
N/M
N/M
EV / Revenue
0.9x
2.2x
2. Growth & Scale
CDRE
Revenue Growth (YoY)
+22.2%
+30.2%
Earnings Growth (YoY)
+0.0%
+37.5%
TTM Revenue (USD)
$46M
$733M
Market Cap
$33.7M
$1.3B
3. Profitability & Quality
CDRE
Gross Margin
70.1%
42.8%
Operating Margin
-21.8%
12.5%
Net Profit Margin
-33.1%
5.6%
Return on Equity (ROE)
-173.5%
11.6%
4. Balance Sheet & Cash Flow
CDRE
Cash Generation (TTM)
-$9.1M
$76M
Cash Flow Margin
-20.0%
10.4%
Net Cash / Leverage
$8.9M Net Debt (3.44x D/E)
$330M Net Debt (1.08x D/E)
Dividend Yield
None (0.00%)
1.24%
5. Options & Positioning
MYO
Options Structure Phase
UNCLASSIFIED
SURGE
Current IV / %ile
266.0% (81st %ile)
47.3% (2nd %ile)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Markdown
DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat
CDRE
OpEx & R&D Intensity
N/A
30.3% of Rev ($222M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Medical Devices Operator
Aerospace & Defense Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: MYO (1) vs CDRE (9)| Institutional Metric | MYO | CDRE | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $33.7M | $1.3B | CDRE | |
| Trailing P/E Ratio | N/M | 33.6x | CDRE | |
| Forward P/E Ratio | N/M | 18.5x | CDRE | |
| Revenue Growth (YoY) | +22.2% | +30.2% | CDRE | |
| Operating Margin (TTM) | -21.8% | 12.5% | CDRE | |
| Net Profit Margin | -33.1% | 5.6% | CDRE | |
| Return on Equity (ROE) | -173.5% | 11.6% | CDRE | |
| 52-Week Range Position | 16% ($1–$2) | 22% ($24–$49) | CDRE | |
| Beta / 30D Volatility | 2.22β · 107% Vol | 0.87β · 42% Vol | CDRE | |
| Unified Institutional Score | 40.1 / 100 (SELL) | 39.6 / 100 (SELL) | MYO | |
| Trailing 12M Revenue (USD) | $46M | $733M | Scale | |
| Gross Profit Margin (TTM) | 70.1% | 42.8% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 0.9x EV/Rev | N/M PEG · 2.2x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$9.1M ($8.9M Net Debt (3.44x D/E)) | $76M ($330M Net Debt (1.08x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
CDRE +33.49 pp
3M Horizon
CDRE +30.68 pp
6M Horizon
CDRE +19.18 pp
1Y Horizon
MYO +38.68 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MYO Revenue | CDRE Revenue | MYO Op. Margin | CDRE Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -430.8% | N/A | MYO |
| FY2019 | $0M | N/A | -281.3% | N/A | MYO |
| FY2020 | $10M | $400M | -138.5% | 12.3% | CDRE |
| FY2021 | $10M | $430M | -74.1% | 12.1% | CDRE |
| FY2022 | $20M | $460M | -68.6% | 3.7% | CDRE |
| FY2023 | $20M | $480M | -42.8% | 11.7% | CDRE |
| FY2024 | $30M | $570M | -19.1% | 11.8% | CDRE |
| FY2025 | $40M | $610M | -35.2% | 11.0% | CDRE |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
MYO
UNCLASSIFIED
Current IV
266.0%
IV Percentile
81st %ile
Put/Call OI Skew
N/A
IV Regime
Extreme (>80th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact MYO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
CDRE
SURGE
Current IV
47.3%
IV Percentile
2nd %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BEARISH
OBV Flow
DISTRIBUTION
Exact CDRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
MYO Moat Profile
Cyclical / Execution-Driven Positioning
Medical Devices Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
CDRE Moat Profile
Cyclical / Execution-Driven Positioning
Aerospace & Defense Operator
OpEx & R&D Reinvestment
30.3% of Rev ($222M)
90D Engineering Disclosures
0 Published
Investor FAQ MYO vs CDRE Key Questions & Quantitative Answers
As of Nov 20, 2026, Cadre Holdings, Inc. (CDRE) is the stronger overall head-to-head candidate over Myomo Inc. (MYO) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). MYO carries a Unified Composite Score of 40.1/100 (SELL) at $0.81 (N/M Forward P/E, -21.8% operating margin), whereas CDRE carries 39.6/100 (SELL) at $29.45 (18.5x Forward P/E, 12.5% operating margin). Defensive Composite Rating Caution: Although CDRE compares more favorably head-to-head, both MYO (40.1/100 SELL) and CDRE (39.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: MYO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.7); meanwhile CDRE trades in a Neutral technical trend (SURGE options phase, RSI 42.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CDRE leads the Growth & Scale pillar: MYO posts +22.2% YoY revenue growth and +0.0% YoY earnings growth on $46M TTM revenue (70.1% gross margin, -21.8% operating margin), compared with CDRE at +30.2% YoY revenue growth and +37.5% YoY earnings growth on $733M TTM revenue (42.8% gross margin, 12.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), MYO cumulative revenue shifted +300.0% while CDRE shifted +52.5%. In operating R&D and SG&A reinvestment, MYO deploys N/A (0 90-day corporate R&D disclosures) versus 30.3% of Rev ($222M) (0 disclosures) for CDRE.
CDRE screens cheaper on headline valuation multiples. MYO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.9x EV/Revenue (-20.0% FCF margin), whereas CDRE trades at 18.5x Forward P/E, 33.6x Trailing P/E, N/M PEG, and 2.2x EV/Revenue (10.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MYO (-173.5% ROE) versus CDRE (11.6% ROE) capital efficiency.
In options market volatility and institutional positioning, MYO carries 266.0% implied volatility (81st %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.22β · 107% Vol realized risk). By comparison, CDRE carries 47.3% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.87β · 42% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
CDRE vs MYO · Reverse Pair
CDRE vs VVX
· Sector Peer
CDRE vs DCO
· Sector Peer
CDRE vs LOAR
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking